Oncology Pharma, Inc. engages in the development, manufacture and commercialization of therapeutics. The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San Francisco, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ONPH is 0.000001 USD — it hasn't changed in the past 24 hours. Watch Oncology Pharma Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Oncology Pharma Inc. stocks are traded under the ticker ONPH.
ONPH stock hasn't changed in a week, the last month showed zero change in price, over the last year Oncology Pharma Inc. has showed a −99.90% decrease.
ONPH reached its all-time high on Aug 16, 2013 with the price of 375,000.000000 USD, and its all-time low was 0.000001 USD and was reached on Nov 8, 2023. View more price dynamics on ONPH chart. See other stocks reaching their highest and lowest prices.
ONPH stock is 9.90 K% volatile and has beta coefficient of −281.16. Track Oncology Pharma Inc. stock price on the chart and check out the list of the most volatile stocks — is Oncology Pharma Inc. there?
No, ONPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ONPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Oncology Pharma Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Oncology Pharma Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Oncology Pharma Inc. stock shows the sell signal. See more of Oncology Pharma Inc. technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.